started · updated
Sartorius receives price target hike from Jefferies
Jefferies has raised its price target for laboratory equipment manufacturer Sartorius from 307 to 315 euros, maintaining a ‘Buy’ rating. The decision follows third-quarter financial results that confirmed a recovery within the Bioprocess Solutions (BPS) division.
Analysts noted that strength in the Lab Products & Services (LPS) segment is expected to drive annual targets upward. The focus remains on the sustainable stabilization of product and service revenues, particularly within critical life-science workflows.
Entities
James Vane-Tempest · Jefferies · Sartorius · Sartorius Stedim Biotech